LONDON, Oct. 6 /PRNewswire/ -- The 7th Annual BioPartnering Europe
conference (BPE) which takes place on October 18-19, 1999 in London at the
Queen Elizabeth II Conference Centre, will feature a special discussion called
'European Venture Capital Speaks Out', moderated by Robert Lee Kilpatrick
(Technology Vision Group LLC) and including Chris Evans (Merlin Ventures),
Paul Haycock (Apax Partners), Alan Goodman (Avlar BioVentures), and
Rob Zegelaar (Atlas Ventures). The discussion is followed by a networking
reception at the end of the conference.
As BPE continues to grow, it has become an increasingly efficient venue
for members of the venture and financial communities to review the latest in
life science technology and to mingle with dealmakers from both the pharma and
biotechnology communities. Indeed, this year more than 50 venture capital
companies, investment banks and investment advisors are sending
representatives to the 7th Annual BioPartnering Europe (BPE).
These include the following: 3i plc, A.M. Pappas & Associates LLC,
Abingworth Management Ltd, Advent Limited, Alice Ventures Srl, Apax Partners
& Co., Atlas Venture, Avlar BioVentures Ltd, BancBoston Robertson Stephens,
BankInvest, BI Asset Management, Beeson Gregory Limited, Biomedical
Investment, CIBC World Markets, Close Brothers Equity Markets, Comdisco
Venture Group, Davy Stockbrokers, Dresdner Bank, Dresdner Kleinwort Benson,
E. M. Warburg, Pincus & Co. International, EASDAQ, Egan & Talbot Limited,
EndPoint Merchant Group Inc., Genome Securities, Inc., GIMV n.v.,
Goldman Sachs International, Hambrecht & Quist LLC, Immunity Care & Research,
Inc., ING Barings LLC, Jafco Inc., Ladenburg Thalmann & Co. Inc., Lehman
Brothers, Lipworth Capital Ltd, Merlin Ventures, Miller Tabak + Co. LLC,
MPM Asset Management, MVM Limited, Nomura International plc, Oddo et Cie,
Puilaetco-De Laet Poswick, Bankers, Quartz Capital Partners Limited,
Rothschild Bioscience Unit, Salomon Smith Barney, SG Cowen International L.P.,
SG Cowen Securities Corporation, Smedvig Capital, Sofinnova Partners,
Translink International Ltd., TVM Techno Venture Management III GmbH, Venture
Capital Investment Corp., Warburg Dillon Read, West Midlands Enterprise Board
Limited.
In recognition of their growing involvement, BPE this year provides a
special session catering to these interests. This venture capital plenary
joins BPE's unique line up of Open House sessions, Emerging Company
Presentations, and the Champagne Reception at Whitehall Palace.
Technology Vision Group LLC is a Soquel, California-based company that
offers products and services to bioscience and pharmaceutical firms in the
areas of strategic planning and implementation, competitive intelligence,
asset management, alliance monitoring and business development. To attend the
7th Annual BioPartnering Europe, please contact TVG, phone 831-464-7100
fax 831-464-4240 email biopartnering@techvision.com or visit website at
http://www.biopartnering.com .
SOURCE Technology Vision Group LLC
 back to top
Related links:
http://www.biopartnering.com
http://www.prnewswire.com
CONTACT:
Nancy E. Connelly, Director, Conference Group
of Technology Vision Group LLC, 831-464-7100, or fax,
831-464-4240, or neconnelly@techvision.com
|
